ArticleThe British journal of ophthalmology2014
Negative outcome Charles Bonnet syndrome.
Article in The British journal of ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 101 citations in OpenAlex.
- Charles Bonnet syndrome in patients referred for cataract surgery.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- 'Everywhere I turn, I'm blocked': a qualitative exploration of experiences of Charles Bonnet syndrome and its impact on physical activity and falls.Age and ageing · 2026Article
- Beyond Charles Bonnet Syndrome: A Scoping Review of Psychotic Symptoms in Vision Loss.Alpha psychiatry · 2026Review
- Psychological Profile and Visual Function in Charles Bonnet Syndrome: A Preliminary Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
- Review
- Charles Bonnet Syndrome: associations between psychosocial measures and visual hallucination characteristics in the visually impaired.BMJ open ophthalmology · 2026Article
- Management of Charles Bonnet syndrome in routine eye care services.Eye (London, England) · 2026Article
- Charles bonnet syndrome with subsequent depression in acute angle-closure glaucoma: a case report.Oxford medical case reports · 2026Article
- Compensatory hallucinogenesis across three neuropsychiatric disorders: a Bayesian account.Brain communications · 2026Review
- Understanding healthcare accessibility for military veterans living with Charles Bonnet Syndrome: co-production of a psychoeducational toolkit.Frontiers in psychology · 2026Article
- Charles Bonnet syndrome in adults with inherited retinal disease: prevalence and patient perspectives.BMJ open ophthalmology · 2025Article
- Coexistence of Charles Bonnet Syndrome and occipital epilepsy: A diagnostic challenge.Epilepsy & behavior reports · 2025Article
- Awareness of Charles Bonnet syndrome among ophthalmologists: a survey study.International ophthalmology · 2025Article
- From research to action: recommendations for Charles Bonnet syndrome care and policy.BMJ open ophthalmology · 2025Article
- Article
- Charles Bonnet Syndrome associated with unilateral vision loss: A new diagnostic perspective.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025Review
- Article
- Charles Bonnet syndrome among visually impaired military veterans: findings from a UK screening and survey study.BMJ open ophthalmology · 2025Article
- Filling in the Blind Spot: Integrating Charles Bonnet Syndrome Screening in Ophthalmology.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
backgroundCharles Bonnet Syndrome (CBS) is widely considered a transient condition without adverse consequence, questioning the need for treatment. Yet, while this view may be true of the majority of people with CBS, it is recognised that some have negative experiences and outcomes. Here, we attempt to better understand negative outcome CBS and the factors that influence it.
methods4000 members of the Macular Society were sent a structured questionnaire covering the phenomenology of CBS, its prognosis and impact, symptom reporting, patient knowledge and sources of information.
results492 people with CBS were identified. Kaplan-Meier analysis suggested 75% had CBS for 5 years or more. Thirty-two per cent had negative outcome. Factors associated with negative outcome were: (1) frequent, fear-inducing, longer-lasting hallucination episodes, (2) one or more daily activities affected, (3) attribution of hallucinations to serious mental illness, (4) not knowing about CBS at the onset of symptoms. Duration of CBS or the type of content hallucinated were not associated with negative outcome.
conclusionsCBS is of longer duration than previously suspected with clinically relevant consequences in a third of those affected. Interventions that reduce the frequency, duration or fear of individual hallucination episodes and education prior to hallucination onset may help reduce negative outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.